"Short‐term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA‐VO2): a randomized clinical trial"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Short‐term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA‐VO2): a randomized clinical trial

This study aimed to evaluate the effect of dapagliflozin on 1 and 3‐month maximal functional capacity in patients with stable heart failure with reduced ejection fraction (HFrEF). Click to show full abstract

This study aimed to evaluate the effect of dapagliflozin on 1 and 3‐month maximal functional capacity in patients with stable heart failure with reduced ejection fraction (HFrEF).

Keywords: heart failure; maximal functional; failure reduced; functional capacity; heart

Journal Title: European Journal of Heart Failure
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended